: J. Mayerle, H. Tilg
: Clinical Update on Inflammatory Disorders of the Gastrointestinal Tract Frontiers of Gastrointestinal Research, Vol. 26
: Karger
: 9783805592956
: 1
: CHF 196.10
:
: Klinische Fächer
: English
: 226
: DRM
: PC/MAC/eReader/Tablet
: PDF/ePUB
Digestive-diseas -associated mortality accounts for a major part of all deaths in Western societies and inflammatory diseases such as GI infections, viral hepatitis, GERD or cancers due to chronic inflammation have a tangible economic and social impact. What further aggravates the situation is the fact that complex immunological disorders have surfaced where anti-infective treatments are not effective. Fortunately, due to breakthroughs in basic research that are being successfully translated into clinical practice, new treatment strategies are constantly evolving. In addition to the development of new therapeutic measures, however, it is also mandatory to review and periodically refine established treatment regimens to reflect current knowledge and ensure up-to-date medical care.
Cover1
Contents6
Preface8
Non-Alcoholic Fatty Liver Disease10
Abstract10
Nomenclature10
Epidemiology and Natural History11
Pathogenesis13
Clinical Features and Investigation15
Therapy16
Conclusions21
References21
Fibrosis in the GI Tract: Pathophysiology, Diagnosis and Treatment Options24
Abstract24
Cellular and Molecular Mechanisms of Fibrosis in the GI Tract24
Liver Fibrosis32
Pancreatic Fibrosis33
Intestinal Fibrosis34
Clinical Evaluation of Fibrosis Progression/Regression34
Potential Anti-Fibrogenic Strategies35
References36
Chronic Hepatitis B: Pathophysiology, Diagnosis and Treatment Options41
Abstract41
Phases of Hepatitis B Infection43
Role of Viral Load43
Immunopathogenesis44
Treatment Options in Chronic Hepatitis B46
Summary48
References49
Chronic Hepatitis C: Pathophysiology, Diagnosis and Treatment Options51
Abstract51
Viral Cycle51
Interferon Signalling and HCV Infection54
Innate and Adaptive Immunity to HCV Infection56
Progression of Fibrosis in Hepatitis C58
Predictive Factors of Response to Treatment59
Genome-Wide Association Studies Identified SNPs in the IL28B Region Associated with Response to Treatment60
Molecular Signatures of Response in Liver60
Standard of Care: Combined PEG-IFN Plus Ribavirin62
Specifically Targeted Antiviral Therapy for HCV62
Conclusion64
Acknowledgment64
References65
Clinical Update on Inflammatory Disorders of the GI Tract: Liver Transplantation68
Abstract68
Primary Sclerosing Cholangitis69
Autoimmune Hepatitis74
PSC and AIH: Similarities and Differences76
References78
Hepatocellular Carcinoma81
Abstract81
Incidence and Epidemiology81
Screening and Surveillance82
Diagnosis and Staging82
Treatment83
Surgical Interventions for Advanced HCC84
Locoablative Therapies with Curative Intent86
Established palliative Therapeutic Intervention for Advanced HCC87
Transarterial Chemoembolization87
Drug Treatment for Advanced HCC88
Non-Established and Experimental Treatment Options89
References89
Coeliac Disease92
Abstract92
Coeliac Disease, Epidemiology and Symptoms92
Pathogenesis of Coeliac Disease94
Genetic and Other Risk Factors98
Oral Tolerance to Gluten98
Intestinal Gluten Transport98
Novel Therapies for Coeliac Disease99
Conclusions99
Acknowledgments101
References101
Anti-TNF Therapy in Inflammatory BowelDiseases104
Abstract104
Methods105
Results105
Conclusion113
References114
Role of Epithelial Cells in Inflammatory Bowel Disease117
Abstract117
Endoplasmic Reticulum Stress118
Autophagy120
NOD2121
Organic Cation Transporters122
NF?B123
Conclusion124
References124
GI Immune Response in Functional GI Disorders127
Abstract127
Introduction127
Presence of Inflammation128
Summary132
References132
Probiotics in GI Diseases135
Abstract135
Probiotics135
Inflammatory Bowel Disease136
H. pylori Infection139
Irritable Bowel Syndrome140
Diverticular Disease141
Conclusions141
References142
Microscopic Colitis144
Abstract144